ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1184 • ACR Convergence 2022

    Intracellular Calcium Signals Regulate the Pro-fibrotic Phenotype of Scleroderma Fibroblasts via Calcium/calmodulin-dependent Kinase II

    Sirapa Vichaikul1, William Brodie2, Megan Mattichak2, Qi Wu2, Dinesh Khanna2 and Eliza Pei-Suen Tsou2, 1Michigan Medicine, Howell, MI, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: We performed an in-depth analysis of the involvement of histone reader bromodomain extra-terminal proteins (BETs) in scleroderma (SSc) fibrosis and showed that JQ1, a…
  • Abstract Number: 1183 • ACR Convergence 2022

    Functionally Distinct Fibroblast Populations in Systemic Sclerosis Skin Revealed by Explant Tissue Characterization and Single-cell RNAseq

    Kristina Clark1, Alice Cole2, Shiwen Xu1, Voon Ong3, Christopher Buckley4 and Chris Denton1, 1University College London, London, United Kingdom, 2Royal Free Hospital, London, United Kingdom, 3UCL Medical School Royal Free Campus, London, United Kingdom, 4University of Oxford, Oxford, United Kingdom

    Background/Purpose: Traditional studies of skin fibroblasts in SSc focus on the early "migratory" fibroblast population derived from explant culture of skin biopsies. Single-cell RNAseq has…
  • Abstract Number: 1182 • ACR Convergence 2022

    Evaluation of Efficacy, Immunogenicity, and Toxicity of a Novel Drug Candidate for Scleroderma-associated Interstitial Lung Disease

    Galina Bogatkevich, Ilia Atanelishvili, C. Beth Perry and Richard Silver, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Interstitial lung disease (ILD) is the major cause of mortality among scleroderma (systemic sclerosis, SSc) patients. Although immunosuppressive agents and several other drugs such…
  • Abstract Number: 1176 • ACR Convergence 2022

    Immunoglobulins G from Systemic Sclerosis Patients May Alter the Secretome of Dermal Fibroblasts

    Aurélien Chepy1, Marie Duhamel2, Solange Vivier3, lucile Guilbert3, Eric Hachulla4, Sylvain Dubucquoi3, David Launay3, Michel Salzet2 and Vincent Sobanski3, 1CHU Lille, Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, France, 2Univ. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, Lille, France, 3Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France, 4University of Lille, LILLE, France

    Background/Purpose: Autoantibodies (Aab) are frequent in systemic sclerosis (SSc).Recently, it has been shown that immunoglobulins G (IgG) from SSc promoted a proinflammatory and profibrotic phenotype…
  • Abstract Number: 1188 • ACR Convergence 2022

    Diabetes Burden and Effects of Apremilast on Changes in Cardiometabolic Parameters in Patients with Psoriasis (PsO) or Psoriatic Arthritis (PsA) in a Real-World Setting

    Kate Orroth1, Cristi Cavanaugh2, Xi Qian2, Pam Kumparatana2, Yuri Klyachkin3, Stephen Colgan4 and Myriam Cordey4, 1Amgen, Manhattan Beach, CA, 2OM1, Inc., Boston, MA, 3Amgen, Lexington, KY, 4Amgen, Inc., Thousand Oaks, CA

    Background/Purpose: Patients with PsO and PsA have a higher prevalence of cardiometabolic comorbidities like diabetes compared to the general population. Clinical data have shown apremilast…
  • Abstract Number: 1189 • ACR Convergence 2022

    Natural Language Processing of Chest CT Reports as a Novel Method of Identifying RA-ILD in Real-World Data

    Brent Luedders1, Punyasha Roul2, Yangyuna Yang1, Brendan Cope1, Matt DeVries1, W. Scott Campbell1, Daniel Hershberger1, Jorge Rojas3, Grant Cannon4, Brian Sauer5, Joshua Baker6, Jeffrey Curtis7, Ted Mikuls8 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC, Omaha, NE, 3George E. Wahlen Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, 4Retired, Salt Lake City, UT, 5Salt Lake City VA/University of Utah, Salt Lake City, UT, 6University of Pennsylvania, Philadelphia, PA, 7University of Alabama at Birmingham, Hoover, AL, 8Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Algorithms incorporating diagnostic and procedural codes have recently been developed to identify rheumatoid arthritis-associated interstitial lung disease (RA-ILD) in administrative and electronic health record…
  • Abstract Number: 1179 • ACR Convergence 2022

    Single Cell RNA Sequencing Analysis of Cryopreserved versus Fresh Skin Biopsy Samples from Systemic Sclerosis Patients and Healthy Controls

    Brian Skaug1, Marka Lyons1, Julio Charles1, Maureen Mayes2 and Shervin Assassi3, 1University of Texas McGovern Medical School at Houston, Houston, TX, 2Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, TX, 3McGovern Medical School, University of Texas, Houston, TX

    Background/Purpose: Single cell RNA Sequencing (scRNA-Seq) can elucidate tissue-resident cell populations and gene expression profiles with unprecedented granularity. Application of this approach to systemic sclerosis…
  • Abstract Number: 1187 • ACR Convergence 2022

    Obesity Burden and Effects of Apremilast on Changes in Cardiometabolic Parameters by Obesity Status in Patients with Psoriasis (PsO) or Psoriatic Arthritis (PsA) in a Real-World Setting

    Kate Orroth1, Cristi Cavanaugh2, Xi Qian2, Pam Kumparatana2, Yuri Klyachkin3, Stephen Colgan4 and Myriam Cordey4, 1Amgen, Manhattan Beach, CA, 2OM1, Inc., Boston, MA, 3Amgen, Lexington, KY, 4Amgen, Inc., Thousand Oaks, CA

    Background/Purpose: Obesity prevalence is higher in patients with PsO and PsA than the general population. Weight loss may improve PsO disease severity in obese patients.…
  • Abstract Number: 1200 • ACR Convergence 2022

    Vitamin D and Marine n-3 Fatty Acid Supplementation for Prevention of Autoimmune Disease in the VITAL Randomized Controlled Trial: Outcomes over 7 Years

    Karen Costenbader1, Nancy R Cook2, I-Min Lee2, Jill Hahn3, Joseph Walter1, Vadim Bubes1, Gregory Kotler1, Nicole Yang1, Sonia Friedman1, Erik K Alexander1 and JoAnn E Manson2, 1Brigham and Women's Hospital, Boston, MA, 2Harvard TH Chan School of Public Health, Brigham and Women's Hospital, Boston, MA, 3Brigham and Womens' Hospital, Boston, MA

    Background/Purpose: Strong biologic rationale supports potential effects of both vitamin D and of marine omega-3 (n3) fatty acids for autoimmune disease prevention. Within the randomized…
  • Abstract Number: 1194 • ACR Convergence 2022

    Key Self-reported Determinants of COVID-19 Vaccine Acceptance Among Persons with and Without Autoimmune Disease

    Jenny Gong1, Emma Barnboym2, megan O'Mara3, Natalie Gurevich3, Maya Mattar4, Donald Anthony5, Adam Perzynski2 and Nora Singer6, 1Case Western School of Medicine, Cleveland, OH, 2The MetroHealth System, Cleveland, OH, 3Cleveland Veteran Affairs Medical Center, Cleveland, OH, 4Louis Stokes VA Medical Center, Mayfield Heights, OH, 5Case, VA, Metro, Chardon, OH, 6The MetroHealth System at Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: Patients with autoimmune disease are at increased risk for complications from SARS-CoV-2 infection. We aimed to compare patient perspectives on COVID-19 vaccination among persons…
  • Abstract Number: 1196 • ACR Convergence 2022

    Interaction of Cumulative Inflammation with Smoking and Lipids in Risk Modification of Dementia Among Patients with Rheumatoid Arthritis: A Population-based Cohort Study

    Chanakya Kodishala1, Stephanie Duong2, Cassondra Hulshizer2, Ryan Lennon2, Rabia Javed2, Maria Vassilaki2, Michelle Mielke3, John Davis2, Cynthia Crowson4 and Elena Myasoedova2, 1Mayo Clinic Rochester Minnesota, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Wake Forest University School of Medicine, Winston-Salem, NC, 4Mayo Clinic, Eyota, MN

    Background/Purpose: Patients with rheumatoid arthritis (RA) have increased risk of developing dementia. Systemic inflammation is implicated in the pathogenesis of cognitive decline. However, the association…
  • Abstract Number: 1192 • ACR Convergence 2022

    Celiac Disease in Patients with Systemic Lupus Erythematosus: An Analysis of Nationwide Inpatient Sample

    Jiayi Zheng1, Ruoning Ni2, Guangchen Zou3, Yuhao Zeng4, Naeem ijaz1 and Yani Zhang5, 1The Wright Center for Graduate Medical Education, Scranton, PA, 2Ascension Saint Agnes Hospital, Iowa City, IA, 3Danbury Hospital, Danbury, CT, 4Cleveland Clinic Akron General, Akron, OH, 5MedStar Union Memorial Hospital, Baltimore, MD

    Background/Purpose: Celiac disease is an autoimmune disease characterized by the immunologic reaction to gluten by lymphocytes. Although recent studies suggest an association between celiac disease…
  • Abstract Number: 1203 • ACR Convergence 2022

    The Association Between Anti-Citrullinated Peptide Antibodies and Subclinical Interstitial Lung Disease in Community-Dwelling Adults: The Multi-Ethnic Study of Atherosclerosis

    Jenna Lanz1, Jan Hughes-Austin2, Anna Podolanczuk3, John Kim4, John Austin5, William Robinson6, Ganesh Raghu7, Eric Hoffman8, John Newell Jr8, Jubal Watts Jr9, P. Hrudaya Nath9, Sushilkumar Sonavane10, R. Graham Barr5 and Elana Bernstein1, 1Columbia University, New York, NY, 2University of California, San Diego, San Diego, CA, 3Weill Cornell Medical College, New York, NY, 4University of Virginia School of Medicine, Charlottesville, VA, 5Columbia University Medical Center, New York, NY, 6Stanford University School of Medicine, Palo Alto, CA, 7University of Washington, Seattle, WA, 8University of Iowa, Iowa City, IA, 9University of Alabama at Birmingham, Birmingham, AL, 10Mayo Clinic, Rochester, MN

    Background/Purpose: We previously demonstrated a significant association between serum anti-CCP levels and prevalence of interstitial lung abnormalities (ILA) in community-dwelling adults. A greater number of…
  • Abstract Number: 1202 • ACR Convergence 2022

    Clinical Profile and Trend of Vasculitis in Patients with Acute Coronary Syndrome – Insight from National Database 2010 to 2019

    Palak Shah1, Ana Arevalo2, Rasha Alaameri3, Brinda Basida4, Urja Nagadia5, Sanket Basida5, shobhana Chaudhari6 and Monil Majmundar7, 1Metropolitan Hospital Center, New York Medical College, New York, NY, 2University of Chicago, Chicago, IL, 3New York Medical College/ Metropolitan Program, New York, NY, 4DMC/Sinai Grace Hospital, Detroit, MI, 5University of Missouri, Columbia, MO, 6NYC Health and Hospital/Metropolitan Hospital, New York, NY, 7University of Kansas Medical Center, Kansas City, KS

    Background/Purpose: Vasculitides are characterized by inflammation of vessel walls with reactive damage to mural structures leading to compromise of the lumen. Vasculitides also accelerate atherosclerosis…
  • Abstract Number: 1146 • ACR Convergence 2022

    Genetic Interactions Between T-Cell Receptor Polymorphisms and HLA Amino Acids Contribute to the Risk of Rheumatoid Arthritis

    Chuan Fu Yap1, Paul Martin2, Darren Plant1, John Bowes1, Kazuyoshi Ishigaki3, Saori Sakaue4, Alex Macgregor5, Suzanne Verstappen1, Anne Barton1, Soumya Raychaudhuri6 and Sebastien Viatte1, 1The University of Manchester, Manchester, United Kingdom, 2The University of Manchester, Oberhaching, Germany, 3Riken, Bunkyo-ku, Tokyo, Japan, 4Broad Institute of Harvard and MIT, Cambridge, MA, 5The University of East Anglia, Norwich, United Kingdom, 6Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Rheumatoid arthritis (RA) genetic susceptibility has been well studied with five amino acid positions within the HLA explaining most of the association. Although genome…
  • « Previous Page
  • 1
  • …
  • 560
  • 561
  • 562
  • 563
  • 564
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology